Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma
Stopped early · Phase 2
Conditions studied: Brain Tumors, Central Nervous System Tumors, Medulloblastoma
In brief
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells, but also damages normal cells in the developing brains of children. Combining low-dose radiation therapy in combination with chemotherapy should be effective in treating medulloblastoma while avoiding the long-term side effects of giving higher dose radiation to children with newly diagnosed average risk medulloblastoma.
Key facts
- Study ID
- NCT00031590
- Run by
- Children's Hospital of Philadelphia
- People needed
- 30
- Starts
- 2001-04-01
- Expected to finish
- 2011-05-01
- Last updated by the study team
- 2019-04-25
Who can join
Age: 3 and older, up to 30. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Histologically confirmed medulloblastoma
- Standard-risk disease
- No residual tumor greater than 1.5 cm\^2 after resection by postoperative MRI
- No tumor in the spinal or cerebral subarachnoid space by MRI
- No tumor in the subarachnoid space by Cerebrospinal fluid (CSF)
- No failure to perform staging studies (spine MRI and CSF cytology) preoperatively or postoperatively
- Must begin radiotherapy on study within 28 days after surgery
You may not qualify if…
- Prior radiotherapy and anti-tumor chemotherapy other than corticosteroids are not allowed.
- Pregnant females will not be eligible
- Patients must begin radiotherapy on protocol within 28 days of completion of surgery. Exceptions need to be approved by the Principal Investigator.
- Patients with the following will not be eligible:
- > 1.5cm3 residual tumor following resection as indicated by post-operative MRI.
- tumor in spinal or cerebral subarachnoid space either by MRI of brain and spine
- tumor in subarachnoid space by CSF cytology
- failure to perform staging studies (spine MRI, CSF cytology) either pre- or post- operatively
Where it is running
- Lucile Packard Children's Hospital at Stanford University Medical Center — Palo Alto, California, United States
- Winship Cancer Institute of Emory University — Atlanta, Georgia, United States
- Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.